Ticker Sage

Form 4 · BMY

Bristol Myers Squibb Chief Supply Chain & Ops Karin Shanahan reports exercising or converting 6,281 shares

Part of a grouped insider digest: see all related filings with totals →

Karin Shanahan, Bristol Myers Squibb's EVP, Chief Supply Chain & Operations, filed a Form 4 on Nov 3, 2026 at 4:27 PM ET reporting transactions on Nov 1, 2026.

The filing reports 6,281 shares in an exercise or conversion of a derivative security (code M); and 3,213 shares withheld to pay the exercise price or tax (code F).

After these transactions, the filing lists 28,956 shares of Common Stock, $0.10 par value held directly.

Effect on holdings

Taken together, the rows reported here raised Karin Shanahan's directly held shares by 11.9%, from 25,888 to 28,956.

Reporting person

Transactions as reported

DateCodeSecuritySharesPriceAcquired or disposedHeld afterOwnership
2026-11-01MCommon Stock, $0.10 par value6,281Acquired32,169Direct
2026-11-01FCommon Stock, $0.10 par value3,213$62.48Disposed28,956Direct
2026-11-01MRestricted Stock Units (derivative)6,281Disposed6,281Direct

Codes: P purchase, S sale, A grant or award, M/X/C exercise or conversion, F shares withheld for taxes or the exercise price, G gift. Prices are as reported; some are weighted averages of several trades.

Source

Bristol Myers Squibb company file → · More Bristol Myers Squibb filings

Disclosures

Editor holdings in BMY
The editor holds no position in Bristol Myers Squibb (BMY). As of Nov 11, 2026.
Last updated
Nov 3, 2026

A summary of a public filing for general education, the same for every reader. Not a recommendation to buy, sell or hold BMY.